1. AstraZeneca pays Sobi $95M for priority review voucher — Amgen, Allergan biosimilar of Roche's blockbuster Rituxan clears another US pivotal study — Retrophin sinks as drug “Pharma Bro” Martin Shkreli co-invented fails — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Amgen IT

Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    12
    Views:
    3,592
  2. anonymous
    Replies:
    0
    Views:
    2,766
  3. Anonymous
    Replies:
    38
    Views:
    28,838
  4. naresh
    Replies:
    0
    Views:
    2,387
  5. anonymous
    Replies:
    0
    Views:
    2,698
  6. Anonymous
    Replies:
    4
    Views:
    6,801
  7. Anonymous
    Replies:
    0
    Views:
    2,942
  8. Anonymous
    Replies:
    2
    Views:
    4,556
  9. quickann
    Replies:
    0
    Views:
    2,335
  10. Anonymous
    Replies:
    18
    Views:
    11,351
  11. Anonymous
    Replies:
    0
    Views:
    2,983
  12. Anonymous
    Replies:
    0
    Views:
    3,161
  13. Anonymous
    Replies:
    0
    Views:
    3,208
  14. Anonymous
    Replies:
    1
    Views:
    2,516
  15. Anonymous
    Replies:
    8
    Views:
    5,630
  16. Anonymous
    Replies:
    4
    Views:
    5,619
  17. Anonymous
    Replies:
    23
    Views:
    10,382
  18. Krunk Crush
    Replies:
    8
    Views:
    4,446
  19. Anonymous
    Replies:
    9
    Views:
    5,352
  20. Bill Gates
    Replies:
    1
    Views:
    4,477

Thread Display Options

Loading...